Trade Mark Journal No.2026/017 24 April 2026
UK00004369647 7 April 2026 (5,42)

- Class 5
- Pharmaceutical preparations for the treatment of and prevention of ophthalmic disorders; pharmaceutical preparation for the treatment of and prevention of metabolic syndromes; pharmaceutical preparations for the treatment of cancer.
- Class 42
- Pharmaceutical research and development services; development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of ophthalmic disorders, metabolic syndromes, and cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.
Belite Bio, Inc
Representative: Kilburn & Strode LLP